candesartan migraine
Selected indexed studies
- Candesartan for Treatment of Migraine Headache: A Scoping Review. (Clin Ther, 2025) [PMID:40571531]
- Candesartan versus placebo for migraine prevention in patients with episodic migraine: a randomised, triple-blind, placebo-controlled, phase 2 trial. (Lancet Neurol, 2025) [PMID:40975098]
- Preventive Migraine Treatment. (Continuum (Minneap Minn), 2015) [PMID:26252585]
_Worker-drafted node — pending editorial review._
Connections
candesartan migraine is a side effect of
Sources
- Migraine Headache Prophylaxis. (2019) pubmed
- Candesartan for Treatment of Migraine Headache: A Scoping Review. (2025) pubmed
- Candesartan versus placebo for migraine prevention in patients with episodic migraine: a randomised, triple-blind, placebo-controlled, phase 2 trial. (2025) pubmed
- Preventive Migraine Treatment. (2015) pubmed
- Prevention of Episodic Migraine Headache Using Pharmacologic Treatments in Outpatient Settings: A Clinical Guideline From the American College of Physicians. (2025) pubmed
- Canadian Headache Society guideline for migraine prophylaxis. (2012) pubmed
- Candesartan in migraine prevention: results from a retrospective real-world study. (2020) pubmed
- Preventive drug treatments for adults with chronic migraine: a systematic review with economic modelling. (2024) pubmed
- Migraine prophylaxis. (2008) pubmed
- Clinical effectiveness of pharmacological interventions for managing chronic migraine in adults: a systematic review and network meta-analysis. (2023) pubmed